Efficacy and safety of eltrombopag in the treatment of cancer therapy–induced thrombocytopenia: a large-scale, multicenter, retrospective study in China

Abstract

treatment cycles or adjunctive interventions to prevent bleeding. Overall, this study overcomes the limitations of single-center or small-sample studies by incorporating multiple time points and stratified analyses. It provides robust real-world evidence supporting the optimization of eltrombopag treatment duration and safety monitoring in patients with CTIT, laying a solid foundation for further exploration of the therapeutic potential of eltrombopag in managing CTIT.